TrumpRx, a new government website that acts as a middleman between pharmaceutical companies who sell drugs and the consumers who purchase them, is now live.
President Donald Trump announced the website’s launch during an event at the White House Thursday evening, where he claimed drug prices would decrease by “300, 400, 500 – even 600 percent.”
Only 43 medications are currently available through TrumpRx. In contrast, GoodRx, a popular website that works virtually identically to TrumpRx, offers access to discounted prices for thousands of medications.
Sign Up for NOTUS’ Free Daily Newsletter
Trending
Trump highlighted a few specific drug classes that will be offered at reduced prices through TrumpRx, including drugs used during in vitro fertilization and blockbuster weight loss drugs, such as GLP-1s.
“You’re going to save tremendous amounts of money,” Trump said. “We have many of them, and in a very short period of time, we’ll have just about all of them.”
Other health officials, including Health Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid administrator Mehmet Oz, attended the event, along with Joe Gebbia, director of the National Design Studio, which designed the TrumpRx website.
Since it was first announced last year, TrumpRx has been touted by the Trump administration as a key part of its plan to lower drug costs. But the site will not directly sell drugs. Instead, it will act as a portal through which consumers can access coupons that they can redeem at pharmacies for medications at lower prices than what they would otherwise pay out of pocket.
Under Trump’s “most-favored-nation” pricing initiative, pharmaceutical companies have agreed to not charge more for drugs in the U.S. than they do in other countries, according to an administration official.
TrumpRx will not accept health insurance, an administration official said in 2025. But there will be “no limitations,” they added, on insurance companies that want to allow purchases made on TrumpRx to count toward a deductible or out-of-pocket maximum.
More than a dozen major drug manufacturers agreed to deals with the administration. As part of the agreements, they increased manufacturing in the U.S., set lower prices on new drugs and offered expensive GLP-1 medications at reduced prices to patients on Medicare and Medicaid to avoid new tariffs on their products, which Trump threatened to make as high as 250%.
Companies whose drugs will be available through TrumpRx include Pfizer, AstraZeneca, Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GlaxoSmithKline, Merck & Co., Novartis and Sanofi.
Not all drugs manufactured by those companies will be available on TrumpRx, even after the site adds more medications to the 43 currently listed. Injectable drugs and those given through an infusion will not be offered on the site because it would not be “clinically appropriate” to receive those medications without a provider present, an administration official said last year.
Author
